The evolving role of echocardiography in the assessment of patent foramen ovale in patients with left‐side thromboembolism

Patent foramen ovale (PFO) is the most common congenital cardiac abnormality found approximately in 25% of the adult population The pathophysiological role of paradoxical embolization through the PFO in ischemic stroke is well established. “Self‐expanding double disk” and, more recently, suture‐based “deviceless” systems are used for PFO closure in the setting of secondary prevention after ischemic stroke likely related to paradoxical embolization. Ultrasound plays a significant role in PFO assessment, indication to treatment, intra‐procedural guidance, and follow‐up for those undergoing PFO closure. Three different techniques are frequently used for these purposes: transesophageal echocardiography, transthoracic echocardiogram, and transcranial Doppler. In this review, advantages and limits of these techniques are discussed in detail to improve our skills in detection and treatment of this important condition by using ultrasound.

[1]  J. Carroll,et al.  European position paper on the management of patients with patent foramen ovale. Part II - Decompression sickness, migraine, arterial deoxygenation syndromes and select high-risk clinical conditions. , 2021, European heart journal.

[2]  B. Meier,et al.  European position paper on the management of patients with patent foramen ovale. Part II - Decompression sickness, migraine, arterial deoxygenation syndromes and select high-risk clinical conditions. , 2021, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[3]  G. Sgueglia,et al.  Predictors of Residual Right-to-Left Shunt After Percutaneous Suture-Mediated Patent Fossa Ovalis Closure. , 2020, JACC. Cardiovascular interventions.

[4]  Jae-Kwan Song,et al.  Atrial Septal Aneurysm, Shunt Size, and Recurrent Stroke Risk in Patients With Patent Foramen Ovale. , 2020, Journal of the American College of Cardiology.

[5]  J. Carroll,et al.  Proposal for Updated Nomenclature and Classification of Potential Causative Mechanism in Patent Foramen Ovale-Associated Stroke. , 2020, JAMA neurology.

[6]  F. Buonanno,et al.  Effect of Residual Interatrial Shunt on Migraine Burden After Transcatheter Closure of Patent Foramen Ovale. , 2020, JACC. Cardiovascular interventions.

[7]  J. Messenger,et al.  Congenital and Structural Heart Disease Interventions Using Echocardiography-Fluoroscopy Fusion Imaging. , 2019, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[8]  S. Ho,et al.  Revisiting Anatomy of the Interatrial Septum and its Adjoining Atrioventricular Junction Using Noninvasive Imaging Techniques , 2019, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[9]  Hiroshi Ito,et al.  IMPORTANCE OF ABDOMINAL COMPRESSION VALSALVA MANEUVER AND MICROBUBBLE GRADING IN CONTRAST TRANSTHORACIC ECHOCARDIOGRAPHY FOR DETECTING PATENT FORAMEN OVALE , 2019, Journal of the American College of Cardiology.

[10]  B. Meier,et al.  European position paper on the management of patients with patent foramen ovale. General approach and left circulation thromboembolism. , 2019, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[11]  A. Bortone,et al.  Use of a NobleStitch™ EL Device for PFO Closure. , 2018, Surgical technology international.

[12]  G. Sgueglia,et al.  Novel percutaneous suture-mediated patent foramen ovale closure technique: early results of the NobleStitch EL Italian Registry. , 2018, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[13]  Seung‐Jung Park,et al.  Cryptogenic Stroke and High-Risk Patent Foramen Ovale: The DEFENSE-PFO Trial. , 2018, Journal of the American College of Cardiology.

[14]  S. Silberstein,et al.  Percutaneous Closure of Patent Foramen Ovale in Patients With Migraine: The PREMIUM Trial. , 2017, Journal of the American College of Cardiology.

[15]  Helle K. Iversen,et al.  Patent Foramen Ovale Closure or Antiplatelet Therapy for Cryptogenic Stroke , 2017, The New England journal of medicine.

[16]  David E. Thaler,et al.  Long‐Term Outcomes of Patent Foramen Ovale Closure or Medical Therapy after Stroke , 2017, The New England journal of medicine.

[17]  Jean-Marc Schleich,et al.  Patent Foramen Ovale Closure or Anticoagulation vs. Antiplatelets after Stroke , 2017, The New England journal of medicine.

[18]  J. Spence,et al.  Transcranial Doppler is Complementary to Echocardiography for Detection and Risk Stratification of Patent Foramen Ovale. , 2016, The Canadian journal of cardiology.

[19]  S. Windecker,et al.  Percutaneous closure of patent foramen ovale in migraine with aura, a randomized controlled trial. , 2016, European heart journal.

[20]  A. Alexandrov,et al.  Transcranial Doppler versus transthoracic echocardiography for the detection of patent foramen ovale in patients with cryptogenic cerebral ischemia: A systematic review and diagnostic test accuracy meta‐analysis , 2016, Annals of neurology.

[21]  Matt Morgan,et al.  Patent foramen ovale , 2014, Radiopaedia.org.

[22]  R. Grimm,et al.  Guidelines for the Use of Echocardiography in the Evaluation of a Cardiac Source of Embolism. , 2016, Journal of the American Society of Echocardiography.

[23]  Ji Won Kim,et al.  Patent Foramen Ovale and Stroke–Current Status , 2015, Journal of stroke.

[24]  Kijeong Lee,et al.  D-dimer for prediction of long-term outcome in cryptogenic stroke patients with patent foramen ovale , 2015, Thrombosis and Haemostasis.

[25]  J. Rome,et al.  Guidelines for the Echocardiographic Assessment of Atrial Septal Defect and Patent Foramen Ovale: From the American Society of Echocardiography and Society for Cardiac Angiography and Interventions. , 2015, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[26]  H. Katus,et al.  Using the GORE® Septal Occluder (GSO) in challenging patent foramen ovale (PFO) anatomies. , 2015, Journal of interventional cardiology.

[27]  E. Buscarini,et al.  Clinical implications of pulmonary shunting on saline contrast echocardiography. , 2015, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[28]  K. Vemmos,et al.  Embolic Strokes of Undetermined Source in the Athens Stroke Registry: A Descriptive Analysis , 2015, Stroke.

[29]  A. T. te Pas,et al.  The first breaths of life: imaging studies of the human infant during neonatal transition. , 2015, Paediatric respiratory reviews.

[30]  J. Spence,et al.  Recurrent Stroke and Patent Foramen Ovale: A Systematic Review and Meta-Analysis , 2014, Stroke.

[31]  D. Kent,et al.  Recurrent stroke predictors differ in medically treated patients with pathogenic vs other PFOs , 2014, Neurology.

[32]  J. Tobis,et al.  Diagnostic Accuracy of Transesophageal Echocardiogram for the Detection of Patent Foramen Ovale: A Meta‐Analysis , 2014, Echocardiography.

[33]  G. Lip,et al.  Patent foramen ovale and migraine attacks: a systematic review. , 2014, The American journal of medicine.

[34]  S. Connolly,et al.  Embolic strokes of undetermined source: the case for a new clinical construct , 2014, The Lancet Neurology.

[35]  J. Tobis,et al.  Accuracy of transcranial Doppler for the diagnosis of intracardiac right-to-left shunt: a bivariate meta-analysis of prospective studies. , 2014, JACC. Cardiovascular imaging.

[36]  M. Stevenson,et al.  Routine echocardiography in the management of stroke and transient ischaemic attack: a systematic review and economic evaluation. , 2014, Health technology assessment.

[37]  B. Wessler,et al.  Transesophageal Echocardiography in Cryptogenic Stroke and PFO : The Analysis of Putative High Risk Features from the Risk of Paradoxical Embolism ( RoPE ) Database , 2013 .

[38]  V. Chair,et al.  Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. , 2014, Stroke.

[39]  Y. Alsancak,et al.  PEDIATRIC AND CONGENITAL HEART DISEASE Original Studies Short and Long Term Complications of Device Closure of Atrial Septal Defect and Patent Foramen Ovale: Meta-Analysis of 28,142 Patients From 203 Studies , 2013 .

[40]  M. Picard,et al.  Importance of adequately performed Valsalva maneuver to detect patent foramen ovale during transesophageal echocardiography. , 2013, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[41]  T. Bartel,et al.  Contemporary echocardiographic guiding tools for device closure of interatrial communications. , 2013, Cardiovascular diagnosis and therapy.

[42]  J. Carroll,et al.  Closure of patent foramen ovale versus medical therapy after cryptogenic stroke. , 2013, The New England journal of medicine.

[43]  G. Schuler,et al.  Percutaneous closure of patent foramen ovale in cryptogenic embolism. , 2013, The New England journal of medicine.

[44]  R. Felberg,et al.  Closure or medical therapy for cryptogenic stroke with patent foramen ovale. , 2012, The New England journal of medicine.

[45]  S. Cook,et al.  Figulla PFO occluder versus Amplatzer PFO occluder for percutaneous closure of patent foramen ovale , 2011, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[46]  C. Kimmelstiel Device closure of patent foramen ovale—Do similar devices achieve similar results? , 2011, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[47]  G. Rigatelli,et al.  Patent foramen ovale: a comprehensive review for pulmonologists , 2010, Current opinion in pulmonary medicine.

[48]  S. Homma,et al.  Patent Foramen Ovale and Stroke , 2005, Circulation.

[49]  M. Suttorp,et al.  The BioSTAR device versus the CardioSEAL device in patent foramen ovale closure: comparison of mid-term efficacy and safety , 2010 .

[50]  L. Roncon,et al.  Left atrial dysfunction in patients with patent foramen ovale and atrial septal aneurysm: an alternative concurrent mechanism for arterial embolism? , 2009, JACC. Cardiovascular interventions.

[51]  J. Spence,et al.  Cryptogenic stroke and patent foramen ovale: Clinical clues to paradoxical embolism , 2008, Journal of the Neurological Sciences.

[52]  J. Somberg Patent foramen ovale closure devices: thoughts from the circulatory device advisory panel. , 2007, The American journal of cardiology.

[53]  R. Sacco,et al.  Patent foramen ovale and the risk of ischemic stroke in a multiethnic population. , 2007, Journal of the American College of Cardiology.

[54]  T. Woods,et al.  A critical review of patent foramen ovale detection using saline contrast echocardiography: when bubbles lie. , 2006, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[55]  A. Poulose,et al.  Transseptal technique of percutaneous PFO closure results in persistent interatrial shunting , 2005, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[56]  M. Schwerzmann,et al.  Transcatheter treatment of atrial septal aneurysm associated with patent foramen ovale for prevention of recurrent paradoxical embolism in high-risk patients. , 2005, Journal of the American College of Cardiology.

[57]  M. Schwerzmann,et al.  Risk of decompression illness among 230 divers in relation to the presence and size of patent foramen ovale. , 2004, European heart journal.

[58]  P. Rehak,et al.  Persisting eustachian valve in adults: relation to patent foramen ovale and cerebrovascular events. , 2004, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[59]  L. Vignolo,et al.  Inherited Thrombophilic Disorders in Young Adults With Ischemic Stroke and Patent Foramen Ovale , 2003, Stroke.

[60]  C. McMahon,et al.  Use of the transseptal puncture in transcatheter closure of long tunnel-type patent foramen ovale , 2002, Heart.

[61]  R. Levine,et al.  Bed tilt as an effort-independent maneuver to improve patent foramen ovale assessment by transthoracic contrast echocardiography. , 2001, The American journal of cardiology.

[62]  J. Le Heuzey,et al.  Significant association of atrial vulnerability with atrial septal abnormalities in young patients with ischemic stroke of unknown cause. , 2000, Stroke.

[63]  J. Noth,et al.  Frequency of deep vein thrombosis in patients with patent foramen ovale and ischemic stroke or transient ischemic attack. , 1997, The American journal of cardiology.

[64]  T. Meinertz,et al.  Diagnosis of patent foramen ovale by transesophageal echocardiography and correlation with autopsy findings. , 1996, The American journal of cardiology.

[65]  T. Meinertz,et al.  Chiari's network: normal anatomic variant or risk factor for arterial embolic events? , 1995, Journal of the American College of Cardiology.

[66]  E. Ringelstein,et al.  Comparison of transcranial contrast Doppler sonography and transesophageal contrast echocardiography for the detection of patent foramen ovale in young stroke patients. , 1994, The American journal of cardiology.

[67]  J. Seward,et al.  Diagnosis and classification of atrial septal aneurysm by two-dimensional echocardiography: report of 80 consecutive cases. , 1985, Journal of the American College of Cardiology.

[68]  W. Edwards,et al.  Incidence and size of patent foramen ovale during the first 10 decades of life: an autopsy study of 965 normal hearts. , 1984, Mayo Clinic proceedings.